Mercator Medsystems, Inc.

San Leandro, CA

UEI
KLANRKKPWQT4
CAGE
4C796
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
520 McCormick St, San Leandro, CA 94577, USA
Website
mercatormed.com
Founded
2000
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $13,200

Contract awards

Award Agency Obligated Awarded
Mercator medsystems, INC.:1129327 [23-010141] needles 75N90023P00630 NIH Clinical Center $13,200
Microsyringe-infusion catheter HHSF222200750103M Food and Drug Administration $2,250

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Mercator Medsystems, Inc. is a for-profit corporate entity registered in SAM.gov since 2006, located in San Leandro, California, specializing in medical technology and device development focused on innovative drug delivery and therapeutic interventions. The company appears to be primarily focused on developing advanced medical devices and technologies for vascular and interventional medical treatments, with a specific emphasis on creating targeted drug delivery systems and medical devices for complex medical conditions.

In terms of federal contract awards, Mercator Medsystems, Inc. has demonstrated capability in supplying medical equipment and supplies to federal agencies. The most recent federal contract award was a $13,200 purchase order from the NIH Clinical Center, specifically for providing medical needles to support medical research and patient care activities. The contract, awarded on July 26, 2023, is a firm-fixed-price purchase order set to be completed by April 26, 2024. This contract does not appear to have any specific set-aside designations and was awarded directly to Mercator Medsystems as a prime contractor.

Regarding federal grant awards, Mercator Medsystems, Inc. has received research grants from the National Heart, Lung, and Blood Institute (NHLBI) focused on developing innovative medical treatments for deep vein thrombosis (DVT) and post-thrombotic syndrome. Specifically, the company has been awarded two related grants (R44HL160434 and R41HL160434) to research and develop a perivascular anti-inflammatory agent delivery method to prevent post-thrombotic syndrome. These Small Business Innovation Research (SBIR) grants total approximately $1.5 million and involve developing a novel therapeutic approach using localized dexamethasone delivery to reduce inflammation and prevent complications following DVT treatment. The research involves preclinical studies, device engineering, and planned clinical trials to validate the proposed medical intervention.

Quick answers

Is Mercator Medsystems, Inc. registered in SAM.gov?

Yes. Mercator Medsystems, Inc.'s SAM.gov registration is active through August 3, 2027.

How much has Mercator Medsystems, Inc. received in federal contracts?

Federal contracts obligated $13,200 to Mercator Medsystems, Inc. in fiscal years 2023 through 2027.

What is Mercator Medsystems, Inc.'s most recent federal award?

Mercator Medsystems, Inc.'s most recent federal contract award is Mercator medsystems, INC.:1129327 [23-010141] needles (75N90023P00630), from NIH Clinical Center, on July 26, 2023.

On GovTribe

See Mercator Medsystems, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors